ENvue Medical Sets 1-for-12 Reverse Split as FEED Slips

ENvue Medical, Inc. (NASDAQ: FEED) said a 1-for-12 reverse stock split approved by its board is expected to take effect September 1, 2026, cutting shares outstanding from 11,084,616 to about 923,718, with the stock closing at 0.34 on August 28, down 6.36%.

ENvue Medical, Inc. (NASDAQ: FEED) is about to shrink its share count by a factor of twelve. The commercial-stage medical technology company said a reverse stock split at a ratio of 1-for-12 is expected to become effective on September 1, 2026, with the common stock opening for trading on a post-split basis that morning on the NASDAQ Capital Market under the same ticker, "FEED."

The mechanics are straightforward. Every 12 existing shares of common stock, par value $0.001 per share, will be combined into a single share. That takes the 11,084,616 shares of common stock outstanding down to approximately 923,718. The company's authorized share count is untouched at 40,000,000 shares of common stock. No fractional shares will be issued: any fraction created by the combination will be rounded up to the nearest whole share, calculated per stockholder rather than per position or certificate. The board of directors approved the split under authority granted to it.

Investors did not treat the announcement as good news. FEED closed at 0.34, down 6.36% from the prior close of 0.37, and traded in a range of 0.33 to 0.35 on the day, according to market data as of 20:00 GMT on August 28, 2026. The move came against a broadly flat-to-lower session for the major U.S. benchmarks: the S&P 500 tracker (SPY) closed at $769.35, off 0.23%, the Nasdaq 100 tracker (QQQ) at $716.43, down 0.65%, and the Dow tracker (DIA) at $535.06, down 0.03%.

What a reverse split does and does not change

A reverse stock split is arithmetic, not value creation. Combining 12 shares into one multiplies the quoted price and divides the share count; in the absence of any other change, the market capitalization is the same on either side of the transaction. Shareholders own the same slice of the company, just expressed in fewer, higher-priced units.

What does change is the plumbing. A higher nominal price can bring a stock back inside the eligibility screens used by institutions and some brokerages, many of which will not buy or lend against securities trading below a set dollar threshold. It also reduces the number of shares that have to change hands to move the price, which can cut the percentage impact of a single small order.

Two details in ENvue's announcement are worth reading carefully. First, authorized shares stay at 40,000,000. When outstanding shares fall to roughly 923,718 but the authorized pool is left intact, the gap between what is issued and what could be issued widens considerably. That headroom is not itself a plan to issue stock, but it is the capacity to do so without going back to shareholders for more authorization. Second, rounding fractional shares up on a per-stockholder basis is the shareholder-friendly version of this provision: nobody is cashed out of a small position or forced into a taxable fractional settlement.

The listing-compliance question

Companies do reverse splits for several reasons, but on the NASDAQ Capital Market the most common one is the minimum bid price requirement that continued listing depends on. A stock trading in the mid-thirties of a cent is well below the level at which that rule bites, and a 1-for-12 combination is the kind of ratio chosen to clear it with room to spare rather than to scrape past it.

ENvue's announcement, as reported by Baystreet, sets out the ratio, the effective date and the resulting share count but does not, on the facts available here, state a compliance rationale. Investors watching the name should look for the company's own filings and any NASDAQ correspondence for the definitive answer, rather than assume one.

Either way, the compliance benefit of a reverse split is conditional. Exchanges typically require the higher price to hold for a sustained stretch of trading days, not merely to print once at the open. That makes the weeks after September 1 more informative than the day itself.

Why the market often sells the announcement

The negative reaction in FEED is a familiar pattern. Reverse splits are concentrated among small companies whose share prices have already fallen a long way, so the announcement functions as confirmation of the underlying problem rather than a fix for it. Holders who cannot or will not own sub-dollar stocks have generally already gone; the ones left are being told the float is about to become far thinner.

Thin floats cut both ways. With roughly 923,718 shares outstanding after the combination, small changes in demand can produce outsized price swings in either direction, and bid-ask spreads on a post-split micro-cap can be wide relative to the quoted price. Traders sizing positions in the first sessions after September 1 should expect the tape to be less orderly than it was before.

There is also a mechanical wrinkle for anyone holding through the effective date. Brokerage statements will show a smaller position at a higher price per share once the split is processed, and processing does not always complete on day one. Stop-loss and limit orders entered before the split are frequently cancelled or adjusted by brokers; holders with resting orders should check them rather than assume they survive intact.

What to watch after September 1

Three things will determine whether this split accomplishes anything beyond changing the arithmetic.

• Whether the higher price holds. A post-split price that erodes steadily back toward the pre-split equivalent is the outcome that has historically dogged serial reverse splitters. Sustained trading above any relevant listing threshold is the test.
• Whether the authorized-share headroom gets used. With 40,000,000 shares authorized and roughly 923,718 outstanding, the capacity for new issuance is substantial. Any subsequent capital raise would be the most important follow-on event for existing holders.
• Whether commercial progress shows up. ENvue describes itself as commercial-stage, which means revenue exists and the question is its trajectory. No amount of share-count engineering substitutes for that.

For now, the calendar is fixed: trading resumes on a post-split basis at the market open on September 1, 2026, ticker unchanged. The share count is the only certainty in the announcement; the price is not.

Key facts

• Ticker and last close: FEED — 0.34, down 6.36%, as of 20:00 GMT Aug 28, 2026
• Split ratio and date: 1-for-12, expected effective September 1, 2026
• Shares outstanding: 11,084,616 reduced to approximately 923,718
• Authorized shares: Unchanged at 40,000,000 shares of common stock

Frequently asked questions

What exactly is ENvue Medical doing to its shares?

ENvue Medical is carrying out a reverse stock split at a ratio of 1-for-12, expected to become effective on September 1, 2026. Every 12 shares of common stock, par value $0.001 per share, will be combined into one share. Shares outstanding fall from 11,084,616 to approximately 923,718. The stock keeps its existing NASDAQ symbol, FEED.

Does the ticker or exchange change?

No. The company said its common stock will begin trading on a post-split basis at the market open on September 1, 2026, on the NASDAQ Capital Market under the existing trading symbol "FEED." Only the share count and the per-share quoted price change; the listing venue and the symbol stay the same.

What happens to fractional shares?

No fractional shares will be issued. Any fractional share resulting from the 1-for-12 combination will be rounded up to the nearest whole share, calculated on a per-stockholder basis. That means small holders are not cashed out of their positions or left with a fractional entitlement to settle.

How did the stock react to the announcement?

FEED closed at 0.34, down 6.36% from a prior close of 0.37, with a day range of 0.33 to 0.35, as of the last trade at 20:00 GMT on August 28, 2026. Broader benchmarks were modestly lower the same session, with SPY off 0.23% and QQQ down 0.65%.

Why would a company reduce its own share count?

A reverse split raises the nominal price per share without changing the underlying value of a holding. On the NASDAQ Capital Market the most common motivation is meeting the minimum bid price requirement for continued listing. A higher price can also make a stock eligible for institutional mandates and brokerage screens that exclude very low-priced securities.

Why does the unchanged authorized share count matter?

ENvue's authorized total stays at 40,000,000 shares while outstanding shares drop to roughly 923,718. That widens the gap between issued and authorizable stock, giving the company more capacity to issue new shares later without a further shareholder vote. It is not a stated plan to raise capital, but it is worth monitoring for existing holders.

Sources

• ENVUE Falters on Reverse Stock Split — Baystreet

Photo: Rafael Minguet Delgado · Pexels Licence — source